Similarly, since the late-1990s Toronto has been enjoying another boom, which has resulted in entirely new districts, such as ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced a $110 million investment to expand its production of prefillable syringes, helping accelerate ...

Have you been shopping for wellness gear and realized you might be comparing apples to oranges? Red light therapy and ...

CES 2025 is now well underway as we head into the third official day – fourth in total – and we're still scouring the world's ...

Chris Taylor heads up marketing for the GIS Group of Sharp NEC Display Solutions of America, which is the creator of GuestView Guide, a wall-mounted digital concierge for vacation rental managers that ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

ASHEVILLE – The city is poised to begin the formal design process to create a “cultural corridor” between bustling Pack Square and The Block, the historic center of Asheville's Black business district ...

Adapt and Case Study 2.0 offer a fire resilience–oriented riff on the famed midcentury program instigated to address the post ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Dual anti-platelet therapy remains a cornerstone of the treatment for coronary artery disease. When choosing a second anti-platelet, ticagrelor remains a principal agent after the recent PLATO trial ...